Abstract:Brown adipocytes display phenotypic plasticity, as they can switch between the active states of fatty acid oxidation and energy dissipation versus a more dormant state. Cold exposure or β-adrenergic stimulation favors the active thermogenic state, whereas sympathetic denervation or glucocorticoid administration promotes more lipid accumulation. Our understanding of the molecular mechanisms underlying these switches is incomplete. Here we found that LSD1 (lysine-specific demethylase 1), a histone demethylase, r… Show more
“…Studies by Sambeat et al (2016) demonstrated that LSD1 interacts with Zfp516 to activate UCP1 and other BAT genes. Similar to the work of Zeng et al (2016), Sambeat et al (2016) showed that LSD1 ablation in brown fat resulted in impaired BAT development, increased fat mass, and decreased energy expenditure. A previous report demonstrated that Zfp516 interacts with PRDM16, suggesting that LSD1 forms a transcriptional complex to demethylate H3K9 (Dempersmier et al 2015).…”
supporting
confidence: 63%
“…In this issue of Genes & Development, Zeng andcolleagues (pp. 1822-1836) identify lysine-specific demethylase 1 (LSD1) as a pivotal regulator of whole-body energy expenditure by controlling the oxidative and thermogenic activity of brown adipose tissue (BAT).…”
mentioning
confidence: 99%
“…In particular, PRDM16, a key transcriptional coregulator, has been shown to control this process through the induction of BAT-specific genes and repression of select WAT genes most abundantly expressed in visceral WAT (Seale et al 2007;Kajimura et al 2008). In this issue of Genes & Development, Zeng et al (2016) demonstrate that lysine-specific demethylase 1 (LSD1) demethylates H3K4 at genomic loci near WATspecific genes in brown adipocytes by interacting and colocalizing with PRDM16 (Zeng et al 2016). They further show that LSD1 acts independently of PRDM16 to repress hydroxysteroid 11-β-dehydrogenase isozyme 1 (HSD11B1) and prevent the production of anti-thermogenic glucocorticoids (GC).…”
mentioning
confidence: 99%
“…Chromatin immunoprecipitation (ChIP) sequencing (ChIP-seq) analysis of histone modifications has shown that distinct chromatin marks exist in brown and white fat. Zeng et al (2016) showed that PRDM16 association with LSD1, a monohistone and dihistone demethylase, promotes nonshivering thermogenesis by demethylating H3K4 and repressing WATselective genes. They further demonstrated the importance of repressing select genes in establishing the energy-expending character of brown and beige adipocytes and the role played by LSD1 in this mechanism.…”
mentioning
confidence: 99%
“…LSD1 deletion in adipose tissue had a more pronounced metabolic phenotype compared with PRDM16-deficient mice. In fact, Zeng et al (2016) showed that LSD1 represses glucocorticoid-activating enzyme HSD11B1 independently of PRDM16. The deletion of HSD11B1 in adipose-specific LSD1 knockout mice restores energy-expending functions in brown adipocytes, suggesting that increased HSD11B1 expression and elevated GC levels are major contributors to BAT dysfunction in LSD1 knockout mice.…”
In this issue of Genes & Development, Zeng and colleagues (pp. 1822–1836) identify lysine-specific demethylase 1 (LSD1) as a pivotal regulator of whole-body energy expenditure by controlling the oxidative and thermogenic activity of brown adipose tissue (BAT). They show that LSD1 interacts with PRDM16 to repress select white adipose tissue (WAT) genes but also represses hydroxysteroid 11-β-dehydrogenase 1 (HSD11B1) independently of PRDM16 to prevent production of glucocorticoids that impair BAT functions. Their study provides important insight into epigenetic mechanisms regulating the function of BAT.
“…Studies by Sambeat et al (2016) demonstrated that LSD1 interacts with Zfp516 to activate UCP1 and other BAT genes. Similar to the work of Zeng et al (2016), Sambeat et al (2016) showed that LSD1 ablation in brown fat resulted in impaired BAT development, increased fat mass, and decreased energy expenditure. A previous report demonstrated that Zfp516 interacts with PRDM16, suggesting that LSD1 forms a transcriptional complex to demethylate H3K9 (Dempersmier et al 2015).…”
supporting
confidence: 63%
“…In this issue of Genes & Development, Zeng andcolleagues (pp. 1822-1836) identify lysine-specific demethylase 1 (LSD1) as a pivotal regulator of whole-body energy expenditure by controlling the oxidative and thermogenic activity of brown adipose tissue (BAT).…”
mentioning
confidence: 99%
“…In particular, PRDM16, a key transcriptional coregulator, has been shown to control this process through the induction of BAT-specific genes and repression of select WAT genes most abundantly expressed in visceral WAT (Seale et al 2007;Kajimura et al 2008). In this issue of Genes & Development, Zeng et al (2016) demonstrate that lysine-specific demethylase 1 (LSD1) demethylates H3K4 at genomic loci near WATspecific genes in brown adipocytes by interacting and colocalizing with PRDM16 (Zeng et al 2016). They further show that LSD1 acts independently of PRDM16 to repress hydroxysteroid 11-β-dehydrogenase isozyme 1 (HSD11B1) and prevent the production of anti-thermogenic glucocorticoids (GC).…”
mentioning
confidence: 99%
“…Chromatin immunoprecipitation (ChIP) sequencing (ChIP-seq) analysis of histone modifications has shown that distinct chromatin marks exist in brown and white fat. Zeng et al (2016) showed that PRDM16 association with LSD1, a monohistone and dihistone demethylase, promotes nonshivering thermogenesis by demethylating H3K4 and repressing WATselective genes. They further demonstrated the importance of repressing select genes in establishing the energy-expending character of brown and beige adipocytes and the role played by LSD1 in this mechanism.…”
mentioning
confidence: 99%
“…LSD1 deletion in adipose tissue had a more pronounced metabolic phenotype compared with PRDM16-deficient mice. In fact, Zeng et al (2016) showed that LSD1 represses glucocorticoid-activating enzyme HSD11B1 independently of PRDM16. The deletion of HSD11B1 in adipose-specific LSD1 knockout mice restores energy-expending functions in brown adipocytes, suggesting that increased HSD11B1 expression and elevated GC levels are major contributors to BAT dysfunction in LSD1 knockout mice.…”
In this issue of Genes & Development, Zeng and colleagues (pp. 1822–1836) identify lysine-specific demethylase 1 (LSD1) as a pivotal regulator of whole-body energy expenditure by controlling the oxidative and thermogenic activity of brown adipose tissue (BAT). They show that LSD1 interacts with PRDM16 to repress select white adipose tissue (WAT) genes but also represses hydroxysteroid 11-β-dehydrogenase 1 (HSD11B1) independently of PRDM16 to prevent production of glucocorticoids that impair BAT functions. Their study provides important insight into epigenetic mechanisms regulating the function of BAT.
N6‐methyladenosine (m6A) modification has been implicated in the progression of obesity and metabolic diseases. However, its impact on beige fat biology is not well understood. Here, via m6A‐sequencing and RNA‐sequencing, this work reports that upon beige adipocytes activation, glycolytic genes undergo major events of m6A modification and transcriptional activation. Genetic ablation of m6A writer Mettl3 in fat tissues reveals that Mettl3 deficiency in mature beige adipocytes leads to suppressed glycolytic capability and thermogenesis, as well as reduced preadipocytes proliferation via glycolytic product lactate. In addition, specific modulation of Mettl3 in beige fat via AAV delivery demonstrates consistently Mettl3's role in glucose metabolism, thermogenesis, and beige fat hyperplasia. Mechanistically, Mettl3 and m6A reader Igf2bp2 control mRNA stability of key glycolytic genes in beige adipocytes. Overall, these findings highlight the significance of m6A on fat biology and systemic energy homeostasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.